BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 29339540)

  • 1. Radioresistant Cervical Cancers Are Sensitive to Inhibition of Glycolysis and Redox Metabolism.
    Rashmi R; Huang X; Floberg JM; Elhammali AE; McCormick ML; Patti GJ; Spitz DR; Schwarz JK
    Cancer Res; 2018 Mar; 78(6):1392-1403. PubMed ID: 29339540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutaminase Inhibitors Induce Thiol-Mediated Oxidative Stress and Radiosensitization in Treatment-Resistant Cervical Cancers.
    Rashmi R; Jayachandran K; Zhang J; Menon V; Muhammad N; Zahner M; Ruiz F; Zhang S; Cho K; Wang Y; Huang X; Huang Y; McCormick ML; Rogers BE; Spitz DR; Patti GJ; Schwarz JK
    Mol Cancer Ther; 2020 Dec; 19(12):2465-2475. PubMed ID: 33087507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting redox homeostasis in rhabdomyosarcoma cells: GSH-depleting agents enhance auranofin-induced cell death.
    Habermann KJ; Grünewald L; van Wijk S; Fulda S
    Cell Death Dis; 2017 Oct; 8(10):e3067. PubMed ID: 28981107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual targeting of the thioredoxin and glutathione antioxidant systems in malignant B cells: a novel synergistic therapeutic approach.
    Kiebala M; Skalska J; Casulo C; Brookes PS; Peterson DR; Hilchey SP; Dai Y; Grant S; Maggirwar SB; Bernstein SH
    Exp Hematol; 2015 Feb; 43(2):89-99. PubMed ID: 25448488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manipulation of Glucose and Hydroperoxide Metabolism to Improve Radiation Response.
    Floberg JM; Schwarz JK
    Semin Radiat Oncol; 2019 Jan; 29(1):33-41. PubMed ID: 30573182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of human head and neck cancer cells to combined inhibition of glutathione and thioredoxin metabolism.
    Sobhakumari A; Love-Homan L; Fletcher EV; Martin SM; Parsons AD; Spitz DR; Knudson CM; Simons AL
    PLoS One; 2012; 7(10):e48175. PubMed ID: 23118946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective targeting of the cysteine proteome by thioredoxin and glutathione redox systems.
    Go YM; Roede JR; Walker DI; Duong DM; Seyfried NT; Orr M; Liang Y; Pennell KD; Jones DP
    Mol Cell Proteomics; 2013 Nov; 12(11):3285-96. PubMed ID: 23946468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous inhibition of glutathione- and thioredoxin-dependent metabolism is necessary to potentiate 17AAG-induced cancer cell killing via oxidative stress.
    Scarbrough PM; Mapuskar KA; Mattson DM; Gius D; Watson WH; Spitz DR
    Free Radic Biol Med; 2012 Jan; 52(2):436-43. PubMed ID: 22100505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting of the Glutathione, Thioredoxin, and Nrf2 Antioxidant Systems in Head and Neck Cancer.
    Roh JL; Jang H; Kim EH; Shin D
    Antioxid Redox Signal; 2017 Jul; 27(2):106-114. PubMed ID: 27733046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of Radiation Response in Breast Cancer Stem Cells by Inhibition of Thioredoxin- and Glutathione-Dependent Metabolism.
    Rodman SN; Spence JM; Ronnfeldt TJ; Zhu Y; Solst SR; O'Neill RA; Allen BG; Guan X; Spitz DR; Fath MA
    Radiat Res; 2016 Oct; 186(4):385-395. PubMed ID: 27643875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mode of cisplatin-induced cell death in CYP2E1-overexpressing HepG2 cells: modulation by ERK, ROS, glutathione, and thioredoxin.
    Lu Y; Cederbaum A
    Free Radic Biol Med; 2007 Oct; 43(7):1061-75. PubMed ID: 17761302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of carboplatin-mediated lung cancer cell killing by simultaneous disruption of glutathione and thioredoxin metabolism.
    Fath MA; Ahmad IM; Smith CJ; Spence J; Spitz DR
    Clin Cancer Res; 2011 Oct; 17(19):6206-17. PubMed ID: 21844013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukemia cells demonstrate a different metabolic perturbation provoked by 2-deoxyglucose.
    Miwa H; Shikami M; Goto M; Mizuno S; Takahashi M; Tsunekawa-Imai N; Ishikawa T; Mizutani M; Horio T; Gotou M; Yamamoto H; Wakabayashi M; Watarai M; Hanamura I; Imamura A; Mihara H; Nitta M
    Oncol Rep; 2013 May; 29(5):2053-7. PubMed ID: 23440281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined inhibition of glycolysis, the pentose cycle, and thioredoxin metabolism selectively increases cytotoxicity and oxidative stress in human breast and prostate cancer.
    Li L; Fath MA; Scarbrough PM; Watson WH; Spitz DR
    Redox Biol; 2015; 4():127-35. PubMed ID: 25560241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knock-down of glutaminase 2 expression decreases glutathione, NADH, and sensitizes cervical cancer to ionizing radiation.
    Xiang L; Xie G; Liu C; Zhou J; Chen J; Yu S; Li J; Pang X; Shi H; Liang H
    Biochim Biophys Acta; 2013 Dec; 1833(12):2996-3005. PubMed ID: 23954443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caffeic Acid Targets AMPK Signaling and Regulates Tricarboxylic Acid Cycle Anaplerosis while Metformin Downregulates HIF-1α-Induced Glycolytic Enzymes in Human Cervical Squamous Cell Carcinoma Lines.
    Tyszka-Czochara M; Bukowska-Strakova K; Kocemba-Pilarczyk KA; Majka M
    Nutrients; 2018 Jun; 10(7):. PubMed ID: 29958416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers of tumour redox status in response to modulations of glutathione and thioredoxin antioxidant pathways.
    Kengen J; Deglasse JP; Neveu MA; Mignion L; Desmet C; Gourgue F; Jonas JC; Gallez B; Jordan BF
    Free Radic Res; 2018 Feb; 52(2):256-266. PubMed ID: 29320894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-modality imaging to assess metabolic response to dichloroacetate treatment in tumor models.
    Neveu MA; De Preter G; Joudiou N; Bol A; Brender JR; Saito K; Kishimoto S; Grégoire V; Jordan BF; Krishna MC; Feron O; Gallez B
    Oncotarget; 2016 Dec; 7(49):81741-81749. PubMed ID: 28082726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of buthionine sulphoximine in hypoxic and non-hypoxic regions of human cervical carcinoma xenografts.
    Vukovic V; Nicklee T; Hedley DW
    Radiother Oncol; 2001 Jul; 60(1):69-73. PubMed ID: 11410306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an in vitro chemo-radiation response assay for cervical carcinoma.
    Monk BJ; Burger RA; Parker R; Radany EH; Redpath L; Fruehauf JP
    Gynecol Oncol; 2002 Nov; 87(2):193-9. PubMed ID: 12477451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.